Home |
About Us |
Investor Relations |
Products & Services |
Science & Technology |
People |
News & Events |
Contact Us
News |
Events
|
|
 |
|
||
 |
||
| |
|
 |
 |
|
19 February 2004 Additional Listing The Company announces that 1,024,138 new Ordinary Shares of 0.1p each (the 'New Ordinary Shares') have been issued and allotted following an exercise of employee share options. Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM, and admission is expected to become effective at 8 a.m. on Wednesday 25th February 2004. For further information: Robert Morrisson Atwater, Chief Executive Officer Cyprotex plc Tel: +44 (0) 1625 505100 ir@cyprotex.com www.cyprotex.com |
|
|
 |
|
